Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amgen issues voluntary recall of Aranesp prefilled syringes in several countries outside of the United States due to the presence of visible particulates


Wednesday, 13 Aug 2014 04:12pm EDT 

Amgen Inc:Initiated a voluntary recall on June 26, for nine packaged lots of Aranesp (darbepoetin alfa) (500 mcg) prefilled syringes from non-U.S. distributors, wholesalers and a number of hospital pharmacies.Due to the potential presence of cellulose and/or polyester particles observed in a small number of syringes during a routine quality examination.Lots 1042847, 1044141A, 1044141C, 1044141D, 1046891A, 1046891B, 1047394A, 1047622A, and 1047996A are being recalled as a precautionary measure.Evaluations by Amgen found a very low potential to impact patients who may have received the affected product. 

Company Quote

163.46
2.79 +1.74%
26 Dec 2014